Table 4.
Clinical parameters in PH patients versus matched pediatric RRT population
| Dialysis | Transplantation | |||
|---|---|---|---|---|
| PH Patients | Non-PH Patients | PH Patients | Non-PH Patients | |
| Height, mean SD score | −1.5 (−2.9 to −0.1) | −1.4 (−2.1 to −0.7) | −1.3 (−2.0 to −0.6) | −1.4 (−1.7 to −1.1) |
| Laboratory values | ||||
| hemoglobin (g/dl), mean | 9.4 (8.8–10.0)a | 10.4 (10.1–10.7) | 11.7 (11.0–12.4) | 12.0 (11.7–12.3) |
| parathyroid hormone (pg/ml), median | 438 (184–711) | 417 (214–621) | 122 (59–303) | 174 (124–224) |
| albumin (g/L), mean | 32.1 (29.4–34.9)a | 36.0 (34.9–37.2) | 39.4 (37.0–41.9) | 42.4 (40.2–44.5) |
| BP | ||||
| % hypertensive | 59 | 58 | 39 | 50 |
| systolic BP, mean SD score | 1.4 (0.7–2.2) | 1.3 (1.1–1.5) | 0.8 (0.3–1.3) | 1.0 (0.8–1.2) |
| diastolic BP, mean SD score | 1.4 (1.0–1.8) | 1.2 (1.0–1.4) | 0.7 (0.3–1.0) | 0.8 (0.6–0.9) |
Data in parentheses are 95% confidence intervals. PH, primary hyperoxaluria; RRT, renal replacement therapy;
a
Significantly lower in PH patients than in non-PH patients (P<0.05).